A Study of NTRX-07 in Participants With Alzheimer's Disease

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

Czechia

Neuro Health Centrum s.r.o., Brno

Neuropsychiatrie s.r.o., Prague

Hungary

Semmelweis University, Budapest

Poland

Szpital Uniwersytecki W Krakowie, Krakow

Wrocławskie Centrum Alzheimerowskie, Wroclaw